You are here
Dr Nigel Crawford
Dr Crawford is Deputy Director of SAEFVIC (Surveillance of Adverse Events Following Vaccination in the Community), a vaccine safety and clinical immunisation research group based at Murdoch Childrens Research Institute. Having completed his medical undergraduate studies at Flinders University Adelaide, Dr Crawford has a masters of public health from Cardiff University, Wales and a Vaccinology PhD from The University of Melbourne.
The SAEFVIC team is involved in the surveillance and follow-up of adverse events following immunisation (AEFI) in Victoria. Established in 2007, they have had over 7,000 AEFI reports and have published extensively in the scientific literature regarding vaccine safety.
Dr Crawford is also the Head of the Immunisation Service at The Royal Children's Hospital and an expert in the vaccination of special risk groups (e.g. immunosuppressed patients) and the clinical evaluation of adverse events following immunisation. He was the chief technical writer for the special risk section of the Australian Immunisation Handbook (NHMRC 2013) and was recently appointed (2014) to the Australian Technical and Advisory Group on Immunisation (ATAGI).
He also has a keen interest in vaccine education, establishing the Clinical Vaccinology Update (held biannually) in 2012 and the Melbourne VaccineEducation Centre in 2014. Dr Crawford has been involved in paediatric training of junior and senior medical staff and medical student teaching through the University of Melbourne
- Medical Head, Immunisation Services, Department of General Medicine, Royal Children's Hospital
- Senior Fellow, Department of Paediatrics, University of Melbourne
- Nigel completed a Masters of Public Health (Distinction) at Cardiff University (2005)
- He worked as Clinical Immunisation research Fellow for the NHMRC in Immunisation (2006) and in 2007 received a NHMRC postgraduate public health PhD scholarship. (2007-10) for his PhD [2011 the University of Melbourne].
- He has also received a Royal Australian College of Physicians (RACP) travel grant (2008) to attend an advanced vaccinology course in France (ADVAC-May 2011).
- In 2014 Nigel was appointed to the Australian Technical Advisory Group for Immunisation (ATAGI), the peak vaccine advisory body for the Department of Health, Canberra.
Dr Crawford's vaccinology PhD from the University of Melbourne (2011) was titled: 'Optimising Immunisation of special risk groups'. This included clinical research into special risk groups and protection from vaccine preventable diseases, including studies of preterm infants and childhood cancer survivors.
His clinical vaccine safety research has also targeted thorough reviewing of AEFI in the community. This has included studies of influenza vaccines in young infants and investigating Guillain Barre syndrome (GBS) following pandemic H1N1/09 vaccine. Research has also focused on allergic reactions and syncopal and/or seizure episodes following human papillomavirus (HPV) vaccine. SAEFVIC now co-ordinate a national AEFI-Clinical Assessment Network
He is also interested in clinical general paediatic research as a consultant paediatrician within the General Medicine department at the Royal Children's Hospital. His research focus includes vaccine preventable diseases (e.g. whooping cough, varicella, measles) and common childhood infections such as pneumonia and Respiratory syncytial virus (RSV) associated bronschiolitis. He is also part of a national network (PAEDS) which includes the Australian Childhood Encephalitis (ACE) study.
- Establishment of a new of the online vaccine education resource in 2014 called the Melbourne Vaccine Education Centre (MVEC). Visit the website at: http://www.mvec.vic.edu.au/
- AEFI-CAN (Adverse event following immunisation- clinical assessment network)
- Paediatric Active Enhanced Disease Surveillance (PAEDS)
- AusVaxSafety- seasonal influenza vaccine surveillance
CRAWFORD, Nigel W; Clothier, Hazel; Hodgson, Kate; Selvaraj, Gowri; Easton, Mee Lee and Buttery, Jim P Active surveillance for adverse events following immunization Expert Review of Vaccines (2014)
Crawford NW, Hunt RW. Rotavirus vaccine timeliness in special care nurseries. Archives of Disease in Childhood - Fetal and Neonatal Edition. 2014 March 4, 2014:DOI:10.1136/archdischild-2014-306107
CRAWFORD NW, Graham SM. EV71 vaccine: protection from a previously neglected disease.[commentary] The Lancet. 2013 :http://dx.doi.org/10.1016/S0140-6736(13)61124-1
Clothier HJ, Lee KJ, Sundararajan V, Buttery JP, CRAWFORD NW. Human papillomavirus vaccine in boys: background rates of potential adverse events. Med J Aust. 2013;198(10):554-8
CRAWFORD, N.W.; Barfield, Charles; Hunt, Rod W.; Pitcher, H. and Buttery, J.P. Improving preterm infants immunization status: A follow- up audit Journal of Paediatrics and Child Health (2014)
Campbell, Sally and CRAWFORD, Nigel W. Varicella infection in infants less than 12 months Vaccine (2013) 31 2 295-296
Richards, Stephanie; Chalkiadis, George; Lakshman, Raman; Buttery, Jim P and CRAWFORD, Nigel W. Complex regional pain syndrome following immunisation Archives of Disease in Childhood (2012) 97 10 913 - 915
CRAWFORD N.W., Cheng A., Andrews N., Charles P. G., Clothier H. J., Day B., Day T., Gates P., Macdonnell R., Roberts L., Rodriguez -Casero V., Wijeratne T., and Kiers L. Guillain-Barré syndrome following pandemic (H1N1) 2009 influenza A immunisation in Victoria: a self-controlled case series Medical Journal of Australia (MJA) (2012) 197 10 574-578
Crawford, N.W. Immunizations in children with cancer Paediatrics and Child Health (2012) 22 3 121-122
CRAWFORD NW, Bines J, Royle R, Buttery JP. Optimizing immunization in pediatric special risk groups . Expert Review of Vaccines 2011; 10(2):175-86